Bon, "y'a plus qu'à" passer chez l'Homme. Et je vous ai dit que c'était une belle histoire. La dernière partie (pour l'instant) a été publiée dans Nature Medicine en 2019. https://t.co/vG6AwcXAfp
Mentions
Extended reach
Total likes
Video views
Mentions per month
Aug 2019 – May 2025Where it's discussed
-
News82 articles
-
Facebook26 posts
-
Blogs14 articles
-
X / Twitter8 posts
-
YouTube2 videos
-
Reddit2 posts
AI synopsis
What people are saying
Discussions frequently highlight promising studies on Akkermansia's role in obesity and health, as well as criticisms of supplement marketing, reflecting a mix of excitement and skepticism. The tone varies from curious and optimistic to critical, shaping an overall perception that, while impactful, remains cautious about the current evidence.
Most discussions recognize the potential benefits of Akkermansia, though some critiques emphasize limitations or conflicting results.
Discussions are highly interested, referencing multiple studies and considering implications for health and weight management.
Comments current research and marketing strategies, indicating a moderate level of deep engagement with the topic.
The posts suggest the research has moderate influence on perceptions and future research directions, especially regarding probiotic and microbiome therapies.
Abstract in brief
- Metabolic syndrome increases the risk of cardiovascular diseases and type 2 diabetes, and the gut microbiota, particularly Akkermansia muciniphila, may play a role in obesity-related issues.
- A pilot study with overweight participants found that daily supplementation of pasteurized A. muciniphila was safe, improved insulin sensitivity, and lowered cholesterol levels compared to placebo.
- While the supplementation had slight effects on body weight and fat mass, it also showed potential benefits for liver function and inflammation markers after three months without altering overall gut microbiome structure.
Top posts
Most liked on X and Bluesky@graciouswoodsy @sergeantsup There is a bunch of research on akkermansia in particular! https://t.co/4Hs4nOIhtS
Il y a déjà quelques études prometteuses sur ce sujet comme avec la bactérie Akkermansia contre l’obésité , ou le cocktail repoopulate pour les infections au Clostridium difficile. (DOI: 10.1038/s41591-019-0495-2 & DOI: 10.1007/s00535-016-1232-y)
@SKiNNyBane @ChrisPalmerMD https://t.co/l5RsLFdH5b based on this - keto does more Here a migraine example https://t.co/iDoYQUToVT
次世代プロバイオはそもそもまだまだ成熟してない印象ですねー。Akkermansiaのヒト試験が一番進んでいる印象。 https://t.co/PElE4fpdP3
RT @laBioauLabo: Bon, "y'a plus qu'à" passer chez l'Homme. Et je vous ai dit que c'était une belle histoire. La dernière partie (pour l'ins…
All mentions
Enhancing Microbiota Health with Exercise and Diet Optimization
Physical activity increases beneficial bacteria like Akkermansia muciniphila. This video explores how exercise and a healthy diet work together to improve microbiota health and considers the effectiveness of probiotic…
Akkermansia Enhances Gut Barrier and Supports Metabolic Health
Akkermansia is a probiotic bacteria that strengthens the gut lining by boosting mucin production. It helps prevent leaky gut and may improve conditions like rosacea, eczema, and IBS. Scientific studies suggest it…
@graciouswoodsy @sergeantsup There is a bunch of research on akkermansia in particular! https://t.co/4Hs4nOIhtS
@SKiNNyBane @ChrisPalmerMD https://t.co/l5RsLFdH5b based on this - keto does more Here a migraine example https://t.co/iDoYQUToVT
Funny that the marketing of this Belgian Akkermansia "weight control" supplement is based on a study in which they found no statistically significant difference re weight reduction with the placebo group ... @MicrObesity ? https://t.co/rvpdo75aWM https://t.co/mlDATwkdlc https://t.co/DzQxTeQZOX
RT @nishimoto_gut: 次世代プロバイオはそもそもまだまだ成熟してない印象ですねー。Akkermansiaのヒト試験が一番進んでいる印象。 https://t.co/PElE4fpdP3
次世代プロバイオはそもそもまだまだ成熟してない印象ですねー。Akkermansiaのヒト試験が一番進んでいる印象。 https://t.co/PElE4fpdP3
Il y a déjà quelques études prometteuses sur ce sujet comme avec la bactérie Akkermansia contre l’obésité , ou le cocktail repoopulate pour les infections au Clostridium difficile. (DOI: 10.1038/s41591-019-0495-2 & DOI: 10.1007/s00535-016-1232-y)
RT @laBioauLabo: Bon, "y'a plus qu'à" passer chez l'Homme. Et je vous ai dit que c'était une belle histoire. La dernière partie (pour l'ins…
Bon, "y'a plus qu'à" passer chez l'Homme. Et je vous ai dit que c'était une belle histoire. La dernière partie (pour l'instant) a été publiée dans Nature Medicine en 2019. https://t.co/vG6AwcXAfp